Related Experiment Video
Updated: Jun 14, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
IGFBP3 modulation of tumor pathogenesis and cell signaling pathways (Review)
Yanzi Zhang1,2, Xin Lv1,2
1Clinical Laboratory, Children's Hospital Affiliated to Shandong University, Jinan, Shandong 250022, P.R. China.
Abstract:
Insulin-like growth factor binding protein 3 (IGFBP3) is the primary carrier of circulating insulin-like growth factors and is the most extensively studied protein among the six high-affinity insulin-like growth factor binding proteins. Alterations in IGFBP3 at both the transcriptional and post-translational levels may contribute to the occurrence and progression of tumors. The present review focused on the changes in expression levels of IGFBP3 in tumors, as well as the relationship between the activation and inhibition of associated cell signaling pathways, and alterations in cellular biological behavior, aiming to provide a reference for the precise treatment of tumors.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Mitogens and the Cell Cycle
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

